Vienna, VA, United States of America

Haohua Qian

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Illinois. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haohua Qian. Retrieved from https://idiyas.com/inventor/haohua-qian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Haohua Qian: Innovator in Nanoscale Neuromodulation

Introduction

Haohua Qian is a prominent inventor based in Vienna, VA (US). He has made significant contributions to the field of neuromodulation, particularly in the context of retinal neuron activation. His innovative work aims to address critical challenges in treating diseases affecting the retina.

Latest Patents

Haohua Qian holds a patent for a "Nanoscale neuromodulating platform for retina neuron activation apparatus and method." This invention relates to methods and compositions for modulating receptors in postsynaptic neurons of damaged or diseased retinas. The invention also encompasses methods for using these compositions to treat diseases characterized by hyperexcitability, such as epilepsy. He has 1 patent to his name.

Career Highlights

Qian is affiliated with the University of Illinois, where he continues to advance research in neuromodulation. His work is pivotal in developing new therapeutic strategies for retinal diseases, showcasing his commitment to improving patient outcomes.

Collaborations

He has collaborated with notable colleagues, including David R. Pepperberg and Karol Bruzik, contributing to a rich environment of innovation and research.

Conclusion

Haohua Qian's contributions to the field of neuromodulation highlight his role as a leading inventor. His work not only advances scientific understanding but also holds promise for future therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…